Full-Time

Applied AI Health Scientist

Deadline 12/6/26
Booz Allen

Booz Allen

10,001+ employees

Global consulting in strategy, technology, engineering

Compensation Overview

$77.6k - $176k/yr

Washington, DC, USA

In Person

Master's, PhD

Category
AI & Machine Learning (1)
Required Skills
LLM
Microsoft Office
Data Science
Neural Networks
Machine Learning
Word/Pages/Docs
Electronic Health Records (EHR)
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides

Get referred to Booz Allen

See people who can refer or advise you

Requirements
  • At least 5 years of experience applying artificial intelligence in the health domain.
  • Experience applying advanced machine learning methods, including large language models or deep learning, to complex health datasets such as electronic health records, genomic data, and imaging data.
  • Experience with artificial intelligence and machine learning evaluation methods, including robustness, fairness, interpretability, and reproducibility.
  • Experience interacting and communicating with senior-level executives, including Senior Executive Service or General Schedule-15 personnel.
  • Experience using Microsoft Office, Excel, Word, and PowerPoint.
  • Ability to review, critique, and guide artificial intelligence and machine learning technical work.
  • Ability to operate independently within a fast-paced startup environment.
  • A Master's degree in Computer Science, Machine Learning, or Data Science.
Responsibilities
  • Review and evaluate artificial intelligence and machine learning technical proposals and deliverables from external teams.
  • Provide guidance on model development, training methods, and validation strategies to identify risks, gaps, or weaknesses and recommend corrective actions.
  • Advise on the integration of multimodal health data, including electronic health records, imaging, genomic, and patient-reported data.
  • Assess the alignment of model architectures and approaches with program goals and clinical use cases, collaborating with clinical subject-matter experts to ensure artificial intelligence outputs align with clinician expectations and workflows.
  • Evaluate benchmarking results and provide feedback on methodological soundness.
  • Advise on deployment considerations, including interpretability, reliability, and safety in real-world settings.
  • Support program leadership with technical assessments, reports, and recommendations.
  • Produce written reports and presentations that synthesize complex technical findings for various audiences.
  • Provide strategic assessments of new technologies for senior decision makers.
  • Assist with management of current programs and facilitate commercialization of successfully developed technologies.
  • Manage incoming requirements and facilitate engagements within offices and across the agency.
Desired Qualifications
  • Experience in healthcare artificial intelligence or biomedical applications.
  • Experience in the rare disease field.
  • Experience in technical advisory, evaluation, or systems engineering and technical assistance roles.
  • Experience working with interdisciplinary teams including clinicians and patient stakeholders.
  • A Doctorate degree in Computer Science, Machine Learning, Data Science, or a related field.

Booz Allen Hamilton helps government agencies, corporations, and non-profits solve complex technical and strategic problems through strategy, technology, and engineering consulting. Its strengths include cybersecurity, data analytics, and digital transformation for defense, intelligence, and civil sectors. It delivers services via long-term contracts, project-based work, and recurring engagements, blending domain expertise with advanced tech. Its goal is to help clients anticipate threats, optimize operations, and transform organizations in a collaborative, inclusive environment.

Company Size

10,001+

Company Stage

IPO

Headquarters

McLean, Virginia

Founded

1914

Get referred to Booz Allen

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 fiscal 2026 backlog hit $40 billion; book-to-bill reached 1.7x.
  • August 24, 2026 Ultra acquisition strengthens defense technology and can lift margins.
  • Cyber and national security revenue grew despite civil weakness in Q2 fiscal 2026.

What critics are saying

  • Q2 fiscal 2026 revenue fell 8.1%; civil demand stayed delayed.
  • 2025 layoffs cut 2,500 jobs, signaling further civil restructuring into 2027.
  • If federal agencies shift to in-house AI tools, Booz Allen’s consulting model erodes.

What makes Booz Allen unique

  • Aug. 24, 2026: Ultra Mission Solutions adds encrypted edge-compute and defense software.
  • Booz Allen’s Vellox suite targets autonomous intrusions with deception defenses.
  • Its $40 billion backlog and national-security focus outlast civil procurement swings.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Paid Vacation

Professional Development Budget

Remote Work Options

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Sep 14th, 2026
Palantir, Nvidia, Booz Allen restrict Anthropic and OpenAI models over data retention concerns

Palantir Technologies, Nvidia, and Booz Allen Hamilton are restricting use of AI models from Anthropic and OpenAI over data protection concerns, Reuters reported. The companies worry model providers could retain or extract value from sensitive corporate information. Palantir has pressed Anthropic for zero data retention guarantees. Nvidia limits Anthropic's models to less sensitive tasks, favouring its own Nemotron models for proprietary work. Booz Allen has banned staff from using Anthropic's commercial model on cybersecurity projects involving proprietary data. The pushback intensified after Anthropic introduced a 30-day data retention policy in June for its Claude 3.5 model, citing security monitoring needs. Anthropic responded by launching Enterprise Frontier Safeguards, allowing customers to store activity data in their own cloud infrastructure under their encryption keys.

Business Wire
Sep 12th, 2026
Credo AI Announces $21 Million in New Capital, Grows Leadership Team to Match the Rapid Pace of AI Innovation, Emerges as the Standard of Responsible AI Governance

Credo AI, a global leader in AI governance software, today announced that it has raised $21 million in new capital from CrimsoNox Capital, Mozilla Ventures, ...

TechCrunch
Sep 2nd, 2026
HiddenLayer nabs $100M as enterprises rush to secure their AI deployments | TechCrunch

Security companies are scrambling to build products that can monitor not just agents but also the tools and add-ons they use.

PR Newswire
Sep 2nd, 2026
HiddenLayer raises $100M Series B to secure AI agents and autonomous coding systems

HiddenLayer, an AI security company, has raised $100 million in Series B funding led by Delta-v Capital. Participants include Ten Eleven Ventures, Morgan Stanley, M12, and Booz Allen Ventures. The Austin-based firm secures agentic, generative, and predictive AI applications. It will use the capital to expand its enterprise platform, including Agentic Runtime Security and Agent Harness Security, which protects autonomous coding agents at runtime. HiddenLayer's annual recurring revenue grew more than tenfold, and it signed over 50 new platform customers across sectors including banking, pharmaceuticals, and US defence. The company supports a frontier model provider serving more than 700 million weekly users. HiddenLayer's research team holds 39 granted patents and 65 pending patents in adversarial detection and model protection. The firm recently appointed Mike Gesnaldo as chief revenue officer.

Yahoo Finance
Sep 2nd, 2026
Booz Allen unveils Counter AI defence tool as frontier models achieve fully autonomous network intrusion

Booz Allen Hamilton has released a threat report revealing that advanced AI models can now autonomously execute complete network intrusions without human guidance. The firm tested 18 US and Chinese AI models through its Cyber Weapon Index. The report warns that sophisticated cyberattacks are becoming more accessible as costs and expertise requirements decline. Booz Allen found that coordinated Counter AI defences reduced autonomous attacker success by more than 95% in testing. To address these threats, the company launched Vellox Labs Guile, a Counter AI product designed to disrupt autonomous attacks by manipulating what AI attackers see and trust. The system adapts in real time using frontier AI models to evolve its defences against emerging threats. The report emphasises that entire AI systems, not just individual models, now represent the primary unit of cybersecurity risk.